市场调查报告书
商品编码
1403413
至 2030 年真皮填充剂市场预测:按产品、药物类型、材料、配销通路、应用、最终用户和地区进行的全球分析Dermal Fillers Market Forecasts to 2030 - Global Analysis By Product (Biodegradable, Non-Biodegradable and Other Products), Drug Type, Material, Distribution Channel, Application, End User and By Geography |
根据 Stratistics MRC 的数据,2023 年全球皮肤填充剂市场规模为 55 亿美元,预计在预测期内将以 9.8% 的复合年增长率成长,并在 2030 年达到 105 亿美元。
真皮填充剂是一种使用凝胶状材料的微创治疗方法。这些用于改善脸部皮肤的外观,并以注射剂的形式出现。这些治疗可减少皱纹,使外表更年轻。这些治疗有助于减少痤疮疤痕,并用于改善嘴唇和脸部的皱纹。
根据世界卫生组织估计,到2030年,全球六分之一的人口将超过60岁。根据统计,老年人口将从2020年的10亿增加一倍,达到2050年的21亿。
这种治疗被称为微创手术,是使用特殊的手术器械和观察镜进行的。它可以减少多余的脂肪、体积和轮廓,同时专注于细纹和笑纹等脸部异常现象。全球对微创能量紧致皮肤、除皱、脸部塑形和活肤手术的需求很大。因此,微创手术的日益普及预计将推动市场成长。
用于製造永久性真皮填充剂的成分不会被人体消化。因此,身体可能会采取自卫行动,并可能产生感染疾病和生物膜形成等后果。此外,永久性填充剂对人体具有不可逆的危害,且无法去除。人们对使用真皮填充剂的不利影响的日益关注可能会在一定程度上限制市场的发展。
真皮填充剂是一种凝胶状化合物,注入皮下可抚平细纹、软化皱纹并补充失去的体积。这些填充剂不需要手术或停工,是看起来更年轻的有用治疗选择。这种药物被注射到皮下以抚平面部皱纹。透明质酸和羟基磷灰石钙是着名的。真皮填充剂品牌的改进可能有助于市场需求的增加。
成本是择期手术中需要考虑的因素。真皮填充剂的成本会根据手术中使用的类型和数量而有所不同。此手术的费用还取决于应用皮肤填充剂的从业者的培训和经验。真皮填充剂是一种流行的美容手术,可以恢復失去的体积并治疗各种老化征兆。儘管这是一种安全的门诊手术,但由于治疗成本高昂,预计市场需求将受到限制。
COVID-19大流行对美容皮肤科和美容医疗产业产生了负面影响,该行业在国际上经历了生产问题和供应链中断。封锁措施、旅行限制和裁员都导致真皮填充剂的生产、分销和运输延迟,导致各个地区短缺和供应有限。此外,在疫情最严重的时候,包括整容治疗在内的选择性医疗程序受到严格限制。结果,非必要的诊所暂时关闭,美容服务的需求大幅下降。
预计可生物分解性部分在预测期内将是最大的部分。这些产品旨在创造温和、自然的增强效果,同时模仿脸部特征。它可用于改善嘴唇和脸颊等脸部特征,填充皱纹和细纹,并增加脸部体积。与永久性填充剂相比,可生物分解性的皮肤填充剂会随着时间的推移逐渐分解并被身体吸收。这意味着患者可以改变自己的外表,以适应他们不断变化的需求和偏好。
透明质酸领域预计在预测期内将表现出最高的复合年增长率。深层皱纹、细纹和体积损失只是透明质酸皮肤填充剂可以解决的一些问题。它还可用于改善疤痕和其他皮肤缺陷的外观,并强调嘴唇和颧骨。透明质酸填充剂有多种配方,可让医生根据每位患者的特定需求量身订做治疗方案。
预计北美在预测期内将占据最大的市场占有率。这是由于男性越来越受欢迎、永恆美丽的趋势不断增长以及对非手术整容手术的需求不断增长。该地区的居民非常注重美丽和外表吸引力的理想。因此,真皮填充剂作为改善脸部特征和减少老化症状的一种方式,需求量很大。
预计亚太地区在预测期内将维持最高的复合年增长率。随着可支配收入的增加,该地区更多的人可能有能力承担整容手术的费用。由于该地区是热门的医疗旅游目的地,许多人来这里进行整容手术,该地区的产业蓬勃发展。此外,该地区的美丽理想正在不断发展,人们越来越关注大嘴唇和高颧骨等特征。
According to Stratistics MRC, the Global Dermal Fillers Market is accounted for $5.5 billion in 2023 and is expected to reach $10.5 billion by 2030 growing at a CAGR of 9.8% during the forecast period. Dermal fillers are less invasive treatments that employ gel-based materials. These are utilized to enhance the appearance of the facial skin and come in the form of injectables. These treatments contribute to a more youthful appearance by minimizing wrinkles. These procedures are helpful in reducing acne scars and are utilized to improve lips and facial wrinkles.
According to WHO estimates, by 2030, one in every six people in the world will be 60 or older. As per statistics, the geriatric population size will get double from 1 billion in 2020 to 2.1 billion in 2050.
A treatment known as minimally-invasive surgery is one that is carried out with the use of specialized surgical tools and a scope for seeing. It reduces extra fat, volume, and contour while focusing on face abnormalities including fine lines and wrinkles. There is a great demand worldwide for minimally invasive energy-based skin tightening, wrinkle reduction, face sculpting, and skin rejuvenation procedures. Thus, the increasing prevalence of minimally invasive procedures is expected to drive growth in the market.
The ingredients used to make permanent dermal fillers are indigestible to the human body. As a result, the body will probably defend itself, which might result in consequences including infections and the development of biofilms. Furthermore, permanent fillers harm the human body irreversibly and are not removed. A rising number of people's concerns about the negative consequences of using dermal fillers may limit the market's evolution to some extent.
Dermal fillers are compounds that resemble gel and are injected beneath the skin to smooth lines, soften wrinkles, and replenish lost volume. Without requiring surgery or downtime, these fillers are a useful therapeutic option for looking younger. This medication is injected beneath the skin to help plump up wrinkles on the face. This medications come in a variety of forms; the most popular ones are hyaluronic acid and calcium hydroxylapatite, among others. Improvements in dermal filler brands will contribute to increased market demand.
Cost is a factor that is taken into account for elective procedures. Dermal filler costs vary based on the kind and quantity utilized in the procedure. The cost of the procedure also depends on the training and experience of the practitioner applying dermal fillers. Dermal filler is a popular cosmetic operation that may restore lost volume and cure various indications of aging. It is a safe outpatient procedure, but the expensive cost of the treatments is anticipated to limit market demand.
The COVID-19 pandemic had a detrimental influence on the cosmetic dermatology and aesthetic medicine industries, which suffered production issues and supply chain interruptions internationally. Lockdown procedures, travel restrictions, and a smaller labor force all contributed to delays in dermal filler manufacture, distribution, and transit, which in turn resulted in shortages and restricted availability in different areas. Furthermore, at the pandemic's height, there were severe restrictions on elective medical procedures, including beauty treatments. This led to the temporary closure of non-essential clinics and a sharp drop in the demand for cosmetic services.
The biodegradable segment is expected to be the largest during the forecast period. They are intended to create a mild, natural-looking augmentation while imitating the facial features. They can be used to improve facial features like the lips and cheeks, fill in wrinkles and fine lines, and add volume to the face. Biodegradable dermal fillers, in contrast to permanent fillers, are intended to progressively degrade and be absorbed by the body over time. This implies that patients can modify their look to suit their changing demands and tastes.
The hyaluronic acid segment is expected to have the highest CAGR during the forecast period. Deep creases, wrinkles, fine lines, and volume loss are just a few of the issues that can be resolved with hyaluronic acid dermal fillers. They may also be used to improve the look of scars and other skin defects, as well as to accentuate the lips and cheekbones. Because they come in various formulations, practitioners may tailor therapies to the specific requirements of each patient.
North America is projected to hold the largest market share during the forecast period. This is due to males are becoming more popular, there is a growing trend of ageless beauty in the area, and there is an increased need for non-surgical cosmetic operations. The region's populace is very conscious of ideals of beauty and physical attractiveness. Because of this, dermal fillers are in high demand as a way to improve face characteristics and lessen aging symptoms.
Asia Pacific is projected to hold the highest CAGR over the forecast period. More people in the area may afford cosmetic operations as disposable income rises. Due to the region's popularity as a medical tourism destination, many individuals come here for cosmetic procedures-the area industry has grown rapidly. In addition, the region's ideals of beauty are evolving, placing an increasing focus on characteristics like big lips and high cheekbones.
Some of the key players in Dermal Fillers market include Allergan , Anika Therapeutics, Inc., BIOXIS Pharmaceuticals, Elan aesthetics Inc, FillMed Laboratories, Galderma Laboratories, L.P., Merz Pharma, Prollenium Medical Technologies, Teoxane Laboratories, Revance Therapeutics, Inc., Sinclair Pharma, Suneva Medical, Vital Esthetique Laboratories, Contura International ltd., Zimmer Aesthetic and BioPlus Co., Ltd.
In April 2023, Sinclair Pharma announced that it has received European CE mark for Perfectha Lidocaine, a hyaluronic acid dermal filler pre-mixed with lidocaine. This will make the filler more comfortable for patients to receive.
In March 2023, Revance Therapeutics announced that it has submitted a new drug application (NDA) to the US Food and Drug Administration (FDA) for TAO, a hyaluronic acid dermal filler for the correction of moderate to severe facial wrinkles and folds.
In February 2023, Galderma received FDA approval for Restylane Defyne, a hyaluronic acid dermal filler for chin augmentation. This is the first FDA-approved dermal filler specifically for chin augmentation.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.